Coles, Mark

Distinct fibroblast subsets drive inflammation and damage in arthritis

Croft, A. P., Campos, J., Jansen, K., Turner, J. D., Marshall, J., Attar, M., Savary, L., Wehmeyer, C., Naylor, A. J., Kemble, S., et al. (2019) · Nature

Rheumatoid Arthritis Research and TherapiesOsteoarthritis Treatment and Mechanisms

Cited by 976

Transgenic mice with hematopoietic and lymphoid specific expression of Cre

de Boer, J., Williams, A., Skavdis, G., Harker, N., Coles, M., Tolaini, M., Norton, T., Williams, K., Roderick, K., Potocnik, A. J., et al. (2003) · European Journal of Immunology

Animal Genetics and ReproductionCRISPR and Genetic Engineering

Cited by 739

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

Ahern, D. J., Ai, Z., Ainsworth, M., Allan, C., Allcock, A., Angus, B., Ansari, M. A., Arancibia-Cárcamo, C. V., Aschenbrenner, D., Attar, M., et al. (2022) · Cell

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 328

Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology

Nayar, S., Campos, J., Smith, C. G., Iannizzotto, V., Gardner, D. H., Mourcin, F., Roulois, D., Turner, J., Sylvestre, M., Asam, S., et al. (2019) · Proceedings of the National Academy of Sciences

T-cell and B-cell ImmunologyIL-33, ST2, and ILC Pathways

Cited by 203

Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance

Aschenbrenner, D., Quaranta, M., Banerjee, S., Ilott, N., Jansen, J., Steere, B., Chen, Y.-H., Ho, S., Cox, K., Arancibia-Cárcamo, C. V., et al. (2021) · Gut

Inflammatory Bowel DiseasePsoriasis: Treatment and Pathogenesis

Cited by 123

Building confidence in quantitative systems pharmacology models: An engineer's guide to exploring the rationale in model design and development: Building Confidence in QSP Models

Timmis, J., Alden, K., Andrews, P., Clark, E., Nellis, A., Naylor, B., Coles, M., & Kaye, P. (2017) · CPT: Pharmacometrics & Systems Pharmacology

Statistical Methods in Clinical TrialsComputational Drug Discovery Methods

Cited by 5

Lipopolysaccharide lateral mobility in the Gram-negative bacterial outer membrane is confined and governed by interactions within the conserved Lipid A anchor

Nabarro, J., Leaman, R. M., Lenton, S., Mantion, L., Spears, R. J., Coles, M. C., Pushkin, D. O., Fascione, M. A., & Baumann, C. G. (2025) · The EMBO Journal

Lipid Membrane Structure and BehaviorBacterial Genetics and Biotechnology

Cited by 3

Lipopolysaccharide confinement in the bacterial outer membrane is governed by interactions within the conserved Lipid A anchor

Nabarro, J., Leaman, R. M., Lenton, S., Mantion, L., Spears, R. J., Coles, M. C., Pushkin, D. O., Fascione, M. A., & Baumann, C. G. (2026) · The EMBO Journal

Lipid Membrane Structure and BehaviorBacterial Genetics and Biotechnology

Cited by 3